Valute / APGE
APGE: Apogee Therapeutics Inc
36.37
USD
0.25
(0.68%)
Il tasso di cambio APGE ha avuto una variazione del -0.68% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 35.70 e ad un massimo di 37.35.
Segui le dinamiche di Apogee Therapeutics Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
APGE News
- InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics
- Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
- InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics
- Stifel reiterates Buy rating on Apogee Therapeutics stock amid positive AD data
- Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis (APGE)
- Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL)
- Jefferies raises Apogee Therapeutics stock price target to $96 on promising trial data
- Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data
- Apogee Therapeutics stock maintains Buy rating at Citi after positive data
- Dow Dips 1%; Mustang Bio Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Artelo Biosciences (NASDAQ:ARTL)
- Apogee Dives. But It Could Eventually Rival Sanofi's Biggest Moneymaker.
- Top 2 Health Care Stocks That May Plunge This Month - Apogee Therapeutics (NASDAQ:APGE), Phibro Animal Health (NASDAQ:PAHC)
- Why Is Apogee Therapeutics Stock Soaring On Monday? - Apogee Therapeutics (NASDAQ:APGE)
- Apogee stock soars after positive atopic dermatitis trial data
- Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Apogee Enterprises (NASDAQ:APOG)
- Apogee’s atopic dermatitis drug shows strong efficacy in phase 2 trial
- Guggenheim reiterates Buy on Apogee Therapeutics stock ahead of key data
- Apogee Therapeutics stock maintains buy rating at Stifel ahead of data
- Apogee Therapeutics stock maintains buy rating ahead of key trial data
- Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference
- Stifel maintains Buy rating, $35 target on Apogee Therapeutics stock
- Canaccord maintains Buy on Apogee stock, $89 price target
- Why Is Apogee Therapeutics Stock Trading Higher On Monday? - Apogee Therapeutics (NASDAQ:APGE)
- Apogee Therapeutics: Engineering Biologic Dominance (NASDAQ:APGE)
Intervallo Giornaliero
35.70
37.35
Intervallo Annuale
26.20
63.36
- Chiusura Precedente
- 36.62
- Apertura
- 36.65
- Bid
- 36.37
- Ask
- 36.67
- Minimo
- 35.70
- Massimo
- 37.35
- Volume
- 1.014 K
- Variazione giornaliera
- -0.68%
- Variazione Mensile
- -3.27%
- Variazione Semestrale
- 11.43%
- Variazione Annuale
- -29.13%
31 agosto, domenica